Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-16066
Tokarska-Schlattner, M; Zaugg, M; Zuppinger, C; Wallimann, T; Schlattner, U (2006). New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics. Journal of Molecular and Cellular Cardiology, 41(3):389-405.
- Registered users only
Cardiotoxic side-effects represent a serious complication of anticancer therapy with anthracyclines, in particular with doxorubicin (DXR) being the leading drug of the group. Different hypotheses, accentuating various mechanisms and/or targets, have been proposed to explain DXR-induced cardiotoxicity. This review focuses on the myocardial energetic network as a target of DXR toxic action in heart and highlights the recent advances in understanding its role in development of the DXR related cardiac dysfunction. We present a survey of DXR-induced defects in different steps of cardiac energy metabolism, including reduction of oxidative capacity of mitochondria, changes in the profile of energy substrate utilization, disturbance of energy transfer between sites of energy production and consumption, as well as defects in energy signaling. Considering the wide spectrum and diversity of the changes reported, we attempt to integrate these facts into a common framework and to discuss important functional and temporal relationships between DXR-induced events and the possible underlying molecular mechanisms.
|Item Type:||Journal Article, refereed, further contribution|
|Communities & Collections:||04 Faculty of Medicine > Center for Integrative Human Physiology|
04 Faculty of Medicine > University Hospital Zurich > Institute of Anesthesiology
|DDC:||570 Life sciences; biology|
610 Medicine & health
|Deposited On:||18 Mar 2009 19:49|
|Last Modified:||27 Nov 2013 23:12|
|Citations:||Web of Science®. Times Cited: 101|
Scopus®. Citation Count: 122
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page